Atlas Trials

Safety, Tolerability and Pharmacokinetics of KPG-818 in Healthy Subjects

Clinical trial NCT03949426 · COMPLETED

Trial details

NCT number
NCT03949426
Sponsor
Kangpu Biopharmaceuticals, Ltd.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Systemic Lupus Erythematosus
Start date
2019-05-01
Primary completion
2019-09-29
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.